Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2) by Karaderi, Tugce et al.
CONCISE REPORT
Ankylosing spondylitis is associated with the
anthrax toxin receptor 2 gene (ANTXR2)
T Karaderi,1 S M Keidel,1 J J Pointon,1 L H Appleton,2 M A Brown,3 D M Evans,3,4
B P Wordsworth1,2
Handling editor Tore K Kvien
1National Institute for Health
Research Oxford
Comprehensive Biomedical
Research Centre, University of
Oxford, Oxford, UK
2National Institute for Health
Research Oxford
Musculoskeletal Biomedical
Research Unit, University of
Oxford, Oxford, UK
3University of Queensland
Diamantina Institute,
Translational Research Institute,
Brisbane, Queensland,
Australia
4MRC Integrative Epidemiology
Unit, University of Bristol,
Bristol, UK
Correspondence to
Professor B P Wordsworth,
National Institute for Health
Research Musculoskeletal
Biomedical Research Unit,
Nufﬁeld Orthopaedic Centre,
Windmill Rd, Headington,
Oxford OX3 7LD, UK; paul.
wordsworth@ndorms.ox.ac.uk
DME and BPW are joint senior
authors.
Received 28 March 2014
Revised 29 July 2014
Accepted 2 August 2014
Published Online First
28 August 2014
To cite: Karaderi T,
Keidel SM, Pointon JJ, et al.
Ann Rheum Dis
2014;73:2054–2058.
ABSTRACT
Objectives ANTXR2 variants have been associated
with ankylosing spondylitis (AS) in two previous
genome-wide association studies (GWAS) (p∼9×10−8).
However, a genome-wide signiﬁcant association
(p<5×10−8) was not observed. We conducted a more
comprehensive analysis of ANTXR2 in an independent
UK sample to conﬁrm and reﬁne this association.
Methods A replication study was carried out with
2978 cases and 8365 controls. Then, these were
combined with non-overlapping samples from the two
previous GWAS in a meta-analysis. Human leukocyte
antigen (HLA)-B27 stratiﬁcation was also performed to
test for ANTXR2-HLA-B27 interaction.
Results Out of nine single nucleotide polymorphisms
(SNP) in the study, ﬁve SNPs were nominally associated
(p<0.05) with AS in the replication dataset. In the
meta-analysis, eight SNPs showed evidence of
association, the strongest being with rs12504282
(OR=0.88, p=6.7×10−9). Seven of these SNPs showed
evidence for association in the HLA-B27-positive
subgroup, but none was associated with HLA-B27-
negative AS. However, no statistically signiﬁcant
interaction was detected between HLA-B27 and ANTXR2
variants.
Conclusions ANTXR2 variants are clearly associated
with AS. The top SNPs from two previous GWAS
(rs4333130 and rs4389526) and this study
(rs12504282) are in strong linkage disequilibrium
(r2≥0.76). All are located near a putative regulatory
region. Further studies are required to clarify the role
played by these ANTXR2 variants in AS.
INTRODUCTION
The genetic association between ankylosing spon-
dylitis (AS) and human leukocyte antigen (HLA)-
B27 was ﬁrst established 40 years ago.
Subsequently, it has become clear that AS is a poly-
genic disease with over 40 variants at 28 loci
involved.1 These include anthrax toxin receptor 2
(ANTXR2), also known as capillary morphogenesis
gene 2 (CMG2) to take account of its functions in
basement membrane matrix assembly, angiogenesis
and embryonic development.2 Rare ANTXR2 muta-
tions cause the recessive Mendelian conditions
juvenile hyaline ﬁbromatosis and infantile systemic
hyalinosis,3 4 while common upstream variants
show suggestive association with myopia.5 ANTXR2
has no obvious role in AS, but it contains two
single nucleotide polymorphisms (SNP), rs4333130
and rs4389526, which are in strong linkage dis-
equilibrium (LD) in Europeans,6 7 that have shown
suggestive association with AS in two previous
genome-wide association studies (GWAS). In 2010,
the Triple A Australo-Anglo-American
Spondyloarthritis Consortium (TASC) reported
association with the intronic SNP, rs4333130
(p=9.3×10−8)7; and in 2011, the Wellcome Trust
Case Control Consortium 2 (WTCCC2) showed
an association with rs4389526 (meta-analysis
p=9.4×10−8).6 In neither study did the evidence
for association reach the threshold for genome-
wide signiﬁcance (p<5×10−8). Subsequently, two
smaller Chinese studies failed to show association
with ANTXR2.8 9 Unfortunately, neither of the two
strongly associated ANTXR2 SNPs was included in
the recent Immunochip study designed to replicate
and reﬁne suspected genetic associations with AS.1
Consequently, we sought to clarify the potential
association through a more comprehensive analysis
of ANTXR2 in another independent UK sample
prior to starting more detailed analysis of this
region.
MATERIALS AND METHODS
Patients, controls and statistics
The study was approved by the National Research
Ethics Service, Cambridgeshire 4 Research Ethics
Committee, UK (MREC project number 98/5/23).
We studied 2978 AS cases fulﬁlling the 1984 modi-
ﬁed New York Criteria10 who were not in the previ-
ous TASC 20107 or WTCCC2 analyses.6 Cases were
genotyped on nine SNPs within ANTXR2 that had
previously shown evidence of association with AS
(p<0.05) in the TASC 2010 study.7 SNPs were geno-
typed using KASP technology (competitive allele-spe-
ciﬁc polymerase chain reaction ampliﬁcation) by
LGC Genomics (Hoddesdon, UK). Genotyping
assays were validated on KASP panels, and cluster
plots were checked for clearly separated genotype
clusters.
Cases were compared to 8365 children from the
Avon Longitudinal Study of Parents And Children
who had previously been genotyped on the Illumina
550K platform (rs4234848, rs11098965,
rs4444771, rs10000471, rs4333130, rs6839672)
and then imputed to HapMap 2 as previously
described (rs12504282, rs6534639 and rs4640621;
imputation quality R2≥0.98).11 12 Please note that
the study website contains details of all the data that
is available through a fully searchable data dictionary
(http://www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary/).
Control allele frequencies were checked for
Hardy–Weinberg equilibrium (all p>0.05). Allele
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frequencies between cases and controls were compared by logis-
tic regression analysis. Where SNPs were imputed, ‘best guess’
genotypes were used in the calculation (all R2≥0.98). All statis-
tical analyses were carried out using using the software pro-
gramme PLINK (http://pngu.mgh.harvard.edu/purcell/plink).13
Expected power of the study was based on the ORs from the
TASC 2010 GWAS discovery sample.7 We estimate that our
study had 98% statistical power to detect an association corre-
sponding to an allelic OR of 0.82, with a minor allele frequency
of 0.31, an α of 0.05 (two-sided), and a disease prevalence of 4/
1000, assuming an additive model for disease risk (http://www.
dartmouth.edu/~eugened/power-samplesize.php).
Stratiﬁed analyses
Cases and controls were stratiﬁed by HLA-B27 status, and
tested for association using logistic regression analysis. HLA-B27
status of cases and controls was determined using the
rs4349859 marker, which tags HLA-B27 in Europeans with
very high sensitivity and speciﬁcity.6
Meta-analysis
ORs from the TASC 2010 (1236 cases, 3979 controls),
WTCCC2 2011 (1787 cases, 5162 controls) and this study
were combined in an inverse variance meta-analysis assuming a
ﬁxed effects model. Combinability of the studies was deter-
mined using Cochran’s Q test (p>0.05), and the inconsistency
measure (I2) was used to estimate the amount of heterogeneity
across the studies in the meta-analysis. For TASC, the analysis
included correction for four principal components due to the
different ethnicities in that study.7 Genome-wide signiﬁcance
level (p<5×10−8) was used for declaring statistically signiﬁcant
genetic association. Meta-analysis conditioning on rs12504282
was also performed to detect secondary signals at the locus.
Forest plots were produced using the metafor package in R.
ANTXR2-HLA-B27 interaction analysis
Logistic regression analyses were performed in each cohort
using the model (logOdds=B0+HLA-B27(dominant)+ANTXR2
(additive)+ANTXR2xHLA-B27). The logORs and SEs for the
interaction terms were combined in an inverse variance
Table 1 Associations of 9 ANTXR2 SNPs with AS in (1A) the independent replication study, (1B) HLA-B27-positive and (1C) HLA-B27-negative
stratified analyses
Replication study
(A) All cases vs controls (2978 vs 8365)
(B) B27+ cases vs B27+ controls
(1935 vs 696)
(C) B27– cases vs B27– controls
(358 vs 7669)
SNP Minor allele
MAF (%)
cases/controls p Value OR 95% CI p Value OR 95% CI p Value OR 95% CI
rs6534639 C 45/47 0.0005* 0.90 0.85 to 0.95 0.09 0.90 0.79 to 1.02 0.01* 0.83 0.71 to 0.96
rs4234848 G 31/32 0.08 0.94 0.88 to 1.01 0.37 0.94 0.82 to 1.08 0.1 0.88 0.74 to 1.04
rs11098965 C 24/25 0.2 0.96 0.89 to 1.03 0.19 0.91 0.79 to 1.05 0.4 0.93 0.78 to 1.11
rs4444771 G 24/25 0.2 0.95 0.89 to 1.02 0.14 0.90 0.78 to 1.03 0.6 0.96 0.80 to 1.14
rs12504282 C 43/46 0.0001* 0.89 0.84 to 0.94 0.006* 0.84 0.74 to 0.95 0.4 0.93 0.80 to 1.08
rs10000471 C 33/35 0.01* 0.92 0.86 to 0.98 0.03* 0.87 0.76 to 0.99 0.1 0.88 0.75 to 1.04
rs4640621 A 34/36 0.001* 0.90 0.85 to 0.96 0.01* 0.85 0.75 to 0.97 1.0 1.00 0.85 to 1.17
rs4333130 G 34/36 0.002* 0.91 0.85 to 0.97 0.02* 0.86 0.75 to 0.98 1.0 1.00 0.85 to 1.17
rs6839672 A 16/15 0.6 1.02 0.94 to 1.11 0.10 1.16 0.97 to 1.38 0.3 0.90 0.72 to 1.12
Nominally significant (p<0.05) associations are shown (*).
Number of cases and controls in each analysis is also shown in brackets. (B27: HLA-B27).
HLA, human leukocyte antigen; MAF, minor allele frequency; SNP, single nucleotide polymorphism.
Table 2 Associations of ANTXR2 SNPs with AS in (2A) the overall meta-analysis, (2B) HLA-B27-positive and (2C) HLA-B27-negative stratified
meta-analyses
Meta-analysis
(A) All cases vs controls (6001 vs 17 506)
(B) B27+ cases vs B27+ controls
(4555 vs 1427)
(C) B27–cases vs B27–controls
(761 vs 16 079)
SNP p Value OR
Cochran’s Q
p Value I2 (%) p Value OR
Cochran’s Q
p Value I2 (%) p Value OR
Cochran’s Q
p Value I2 (%)
rs6534639 4.5×10−6 0.91 0.77 0 0.08 0.93 0.52 0 0.13 0.92 0.08 60
rs4234848 0.0007 0.92 0.59 0 0.01 0.89 0.44 0 0.57 0.97 0.24 30
rs11098965 7.1×10−5 0.91 0.09 59 0.006 0.87 0.65 0 0.22 0.93 0.70 0
rs4444771 6.4×10−5 0.91 0.11 54 0.005 0.87 0.74 0 0.35 0.94 0.75 0
rs12504282 6.7×10−9 0.88 0.40 0 0.0003 0.85 0.74 0 0.56 0.97 0.68 0
rs10000471 1.2×10−5 0.91 0.66 0 0.0004 0.85 0.81 0 0.40 0.95 0.47 0
rs4640621 1.2×10−8 0.88 0.43 0 0.002 0.87 0.91 0 0.44 0.96 0.36 3
rs4333130 2.5×10−8 0.88 0.35 5 0.003 0.88 0.95 0 0.44 0.96 0.36 2
rs6839672 0.9 1.00 0.48 0 0.1 1.10 0.63 0 0.17 0.90 0.96 0
Three SNPs reached genome-wide significance (p<5×10−8) in the overall meta-analysis.
Number of cases and controls in each analysis is also shown in brackets. (B27: HLA-B27).
AS, ankylosing spondylitis; HLA, human leukocyte antigen; SNP, single nucleotide polymorphism.
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meta-analysis to test for the presence of an ANTXR2-HLA-B27
interaction.
Bioinformatics
LocusZoom was used to display a regional association plot
showing the pairwise LD between the top SNP and the other SNPs
in the meta-analysis (1000 Genomes March 2012 European
panel).14 The University of California, Santa Cruz (UCSC)
genome browser (http://genome-euro.ucsc.edu/index.html) was
used to interrogate the Encyclopaedia of DNA elements
(ENCODE) data for regions of interest containing the associated
SNPs.15 16 Public eQTL databases were used to determine possible
effects of SNPs in the ANTXR2 region on gene expression (eQTL
databases: http://www.sph.umich.edu/csg/liang/imputation/17 and
http://www.hsph.harvard.edu/liming-liang/software/eqtl/; GTEx:
http://www.gtexportal.org; Genevar18: http://www.sanger.ac.uk/
resources/software/genevar/).
RESULTS
Replication study
Five SNPs showed nominal evidence of association (p<0.05) with
AS in the expected direction (table 1A). Four of these SNPs were
also nominally associated with AS in the HLA-B27-positive subgroup
analysis (table 1B), whereas only one of these showed nominal evi-
dence of association in HLA-B27-negative AS (table 1C). There
appeared to be a difference in the point estimates of the ORs
between HLA-B27-positive and negative individuals (with
HLA-B27-positive individuals showing stronger association for most
SNPs) although the CIs around the estimates were wide.
Meta-analysis
In the meta-analysis, three SNPs showed strong evidence of
association with AS (p<5×10−8), while ﬁve SNPs exhibited sug-
gestive associations (4.5×10−6≤p≤0.0007; table 2A). Forest
plots revealed that the direction and strength of the association
was consistent across most SNPs (ﬁgure 1). Conditional analysis
indicated no associations independent of rs12504282 (all
p>0.1). Seven of the SNPs showed nominal evidence for associ-
ation in the HLA-B27-positive AS subgroup (table 2B), but none
was associated with HLA-B27-negative AS (p>0.05; table 2C).
However, no statistically signiﬁcant interaction was detected
between HLA-B27 and ANTXR2 variants (p>0.05).
DISCUSSION
This study convincingly replicated the association between
ANTXR2 variants and AS in an independent UK sample with
three variants reaching genome-wide signiﬁcance level in the
meta-analysis. In the replication study, the strongest association
was with rs12504282 (p=0.0001, OR=0.89, 95% CI 0.84 to
0.94), but there is a high degree of LD across this locus and the
ﬁve SNPs showing signiﬁcant association (table 1A) are distribu-
ted across the locus (ﬁgure 2). In the meta-analysis, eight SNPs
showed evidence of association, three SNPs reaching genome-
wide signiﬁcance; rs12504282 again showed the strongest asso-
ciation (p=6.7×10−9, OR=0.88). Forest plots show that direc-
tion and magnitude of association across the studies in the
meta-analysis are in agreement with overlapping CIs (ﬁgure 1).
The strength of evidence for association appeared to be stron-
ger in HLA-B27-positive patients compared with the HLA-B27
negatives. None of the seven SNPs, which showed nominal evi-
dence of association with HLA-B27-positive AS showed
Figure 1 Forest plots for overall
meta-analysis of 9 single nucleotide
polymorphisms (SNPs). Plots for SNPs
with highly signiﬁcant p-values,
rs12504282 (p=6.7×10−9), rs4640621
(p=1.2×10−8), rs4333130
(p=2.5×10−8) and rs6534639
(p=4.5×10−6) show agreement across
the studies with overlapping CIs. Two
SNPs rs11098965 (I2=59%, Cochran’s
Q p=0.09) and rs4444471 (I2=54%,
Cochran’s Q p=0.11) exhibit some
degree of heterogeneity, but this was
not statistically signiﬁcant (p>0.05).
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nominal association with HLA-B27-negative disease, including
the top SNP rs12504282 (table 1B, C). However, failure to
detect nominal association with ANTXR2 in HLA-B27-negative
AS probably reﬂects reduced statistical power rather than a
genuine epistatic interaction. Consistent with this interpretation,
the ANTXR2-HLA-B27 interaction analysis statistically testing
for an epistatic effect revealed no signiﬁcant ﬁndings. By con-
trast, the well-established epistatic genetic effect between
HLA-B27 and ERAP1 in AS6 can be explained by the functional
synergy between ERAP1 and HLA class I molecules in antigen
processing and presentation.19 It is much less easy to explain a
putative genetic interaction with ANTXR2 where there is no
known functional interplay with HLA-B27 at the molecular
level.
Biological explanations for the consistent associations of
ANTXR2 variants with AS have not yet been forthcoming. The
top SNPs from three different studies,6 7 including this one, are
in close proximity and strongly correlated (rs4333130,
rs4389526 and rs12504282; r2>0.76). Furthermore, these
SNPs are near a putative transcription factor-binding region,
and may therefore affect the expression level of ANTXR2 or
another gene (ﬁgure 2). ANTXR2 is widely expressed in many
tissues. Interrogation of expressed quantitative trait loci (eQTL)
databases revealed SNP rs4690110 with a strong cis-eQTL
effect on ANTXR2 expression in adipose tissue (p=7.6×10−9,
β=0.14),18 but rs4690110 is weakly correlated with the top
SNP rs12504282 (r2=0.27), and adipose tissue is not thought
to be directly relevant to AS. Therefore, it is unlikely that this
cis-eQTL effect explains the observed AS association in this
region. However, the speciﬁc effects of the associated ANTXR2
SNPs may differ in tissues relevant to AS. Of interest,
rs4333130 and rs12504282 have trans-eQTL effects on the
expression of NSMAF on chromosome 8 (allele A, β=−0.27,
p=0.00025) and GPR89A on chromosome 1 (allele T, β=
−0.25, p=0.00088), respectively, in lymphoblastoid cell lines.17
NSMAF encodes a WD-repeat protein potentially playing a role
Figure 2 Regional association plot showing ANTXR2 (CMG2) and all the single nucleotide polymorphisms (SNPs) in the study on the x-axis and
their corresponding −log10p values on the y-axis. Historic sex-averaged recombination rates are also shown in blue (top panel). Linkage
disequilibrium (r2, 1000 Genomes March 2012 European reference panel) between the top SNP rs12504282 (purple) and the other SNPs are also
shown with colour-coding. ENCODE data showing that rs12504282 and the previous top genome-wide association studies (GWAS) SNPs are near a
region of possible enhancer binding are presented in the bottom panel (A) Gene structure; (B) H3K27Ac mark, ie, often found near active regulatory
elements; (C) DNaseI hypersensitivity clusters; (D) Transcription factor ChIP-seq; (E) Chromatin state segmentation; (F) Transcription factor binding
sites by epitope-tag; G- Top SNPs from the previous GWAS (rs4333130 (TASC, 2010) and rs4389526 (WTCCC2, 2011)). These three top SNPs from
three different studies are strongly correlated (rs4389526-rs4333130 r2=1.0, D0=1.0; rs4389526-rs12504282 r2=0.8, D0=1.0; rs4333130-rs12504282
r2=0.76, D0=1.0).
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in regulating tumour necrosis factor-induced cellular responses,
such as inﬂammation. GPR89A encodes G protein-coupled
receptor 89A involved in Golgi apparatus acidiﬁcation possibly
modulating its functions.20 Substantially more work will be
required before the nature of this tantalising genetic association
with AS can be explained at a functional level.
Acknowledgements We are extremely grateful to all the families who took part
in the Avon Longitudinal Study of Parents And Children (ALSPAC), the midwives for
their help in recruiting them, and the whole ALSPAC team, which includes
interviewers, computer and laboratory technicians, clerical workers, research
scientists, volunteers, managers, receptionists and nurses. Ethical approval for the
study was obtained from the ALSPAC Ethics and Law Committee and the Local
Research Ethics Committees. This publication is the work of the authors and DME
will serve as guarantor for the contents of this paper. The authors are also grateful
for the support of the National Ankylosing Spondylitis Society UK and the NIHR
Thames Valley CLRN for their roles in facilitating the recruitment of cases.
Contributors TK performed the statistical analyses and wrote the manuscript. SMK
and JJP contributed to study design and HLA genotyping. LHA prepared and HLA
genotyped samples. MAB contributed to critical revision of the manuscript. BPW and
DME contributed to subject recruitment/data collection and supervised the study. All
authors participated in manuscript drafting and ﬁnal manuscript review.
Funding The UK Medical Research Council, the Wellcome Trust (Grant ref: 092731)
and the University of Bristol provide core support for ALSPAC. TK was funded by the
National Ankylosing Spondylitis Society. SK and JJP were funded by the NIHR Oxford
Comprehensive Biomedical Research Centre (A91202) and by an unrestricted
educational grant from Abbvie. This study was funded in part by grants from
Arthritis Research UK (19536 and 18797).
Competing interests None.
Ethics approval National Research Ethics Service, Cambridgeshire 4 Research
Ethics Committee, UK (MREC project number 98/5/23); ALSPAC Ethics and Law
Committee and Local Research Ethics Committees.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others
to distribute, remix, adapt and build upon this work, for commercial use, provided the
original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
REFERENCES
1 Cortes A, Hadler J, Pointon JP, et al.; International Genetics of Ankylosing
Spondylitis C. Identiﬁcation of multiple risk variants for ankylosing spondylitis
through high-density genotyping of immune-related loci. Nat Genet
2013;45:730–8.
2 Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature
2000;407:249–57.
3 Denadai R, Raposo-Amaral CE, Bertola D, et al. Identiﬁcation of 2 novel ANTXR2
mutations in patients with hyaline ﬁbromatosis syndrome and proposal of a
modiﬁed grading system. Am J Med Genet A 2012;158A:732–42.
4 Hanks S, Adams S, Douglas J, et al. Mutations in the gene encoding capillary
morphogenesis protein 2 cause juvenile hyaline ﬁbromatosis and infantile systemic
hyalinosis. Am J Hum Genet 2003;73:791–800.
5 Kiefer AK, Tung JY, Do CB, et al. Genome-wide analysis points to roles for
extracellular matrix remodeling, the visual cycle, and neuronal development in
myopia. PLoS Genet 2013;9:e1003299.
6 Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27
in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27
in disease susceptibility. Nat Genet 2011;43:761–7.
7 Reveille JD, Sims AM, Danoy P, et al.; Australo-Anglo-American Spondyloarthritis C.
Genome-wide association study of ankylosing spondylitis identiﬁes non-MHC
susceptibility loci. Nat Genet 2010;42:123–7.
8 Chen C, Zhang X, Wang Y. ANTXR2 and IL-1R2 polymorphisms are not associated
with ankylosing spondylitis in Chinese Han population. Rheumatol Int
2012;32:15–19.
9 Guo C, Xia Y, Yang Q, et al. Association of the ANTXR2 gene polymorphism and
ankylosing spondylitis in Chinese Han. Scand J Rheumatol 2012;41:29–32.
10 van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for
ankylosing spondylitis. A proposal for modiﬁcation of the New York criteria. Arthritis
Rheum 1984;27:361–8.
11 Boyd A, Golding J, Macleod J, et al. Cohort Proﬁle: the ‘children of the 90s’—the
index offspring of the Avon Longitudinal Study of Parents and Children. Int J
Epidemiol 2013;42:111–27.
12 Fatemifar G, Hoggart CJ, Paternoster L, et al. Genome-wide association study of
primary tooth eruption identiﬁes pleiotropic loci associated with height and
craniofacial distances. Hum Mol Genet 2013;22:3807–17.
13 Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome
association and population-based linkage analyses. Am J Hum Genet
2007;81:559–75.
14 Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of
genome-wide association scan results. Bioinformatics 2010;26:
2336–7.
15 Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC.
Genome Res 2002;12:996–1006.
16 Rosenbloom KR, Sloan CA, Malladi VS, et al. ENCODE data in the UCSC Genome
Browser: year 5 update. Nucleic Acids Res 2013;41(Database issue):D56–63.
17 Dixon AL, Liang L, Moffatt MF,, et al A genome-wide association study of global
gene expression. Nat Genet 2007;39:1202–7.
18 Yang TP, Beazley C, Montgomery SB, et al. Genevar: a database and Java
application for the analysis and visualization of SNP-gene associations in eQTL
studies. Bioinformatics 2010;26:2474–6.
19 Kochan G, Krojer T, Harvey D, et al. Crystal structures of the endoplasmic reticulum
aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide
trimming. Proc Natl Acad Sci USA 2011;108:7745–50.
20 Maeda Y, Ide T, Koike M, et al. GPHR is a novel anion channel critical for
acidiﬁcation and functions of the Golgi apparatus. Nat Cell Biol 2008;
10:1135–45.
2058 Karaderi T, et al. Ann Rheum Dis 2014;73:2054–2058. doi:10.1136/annrheumdis-2014-205643
Basic and translational research
group.bmj.com on April 5, 2017 - Published by http://ard.bmj.com/Downloaded from 
)ANTXR2anthrax toxin receptor 2 gene (
Ankylosing spondylitis is associated with the
Evans and B P Wordsworth
T Karaderi, S M Keidel, J J Pointon, L H Appleton, M A Brown, D M
doi: 10.1136/annrheumdis-2014-205643
28, 2014
2014 73: 2054-2058 originally published online AugustAnn Rheum Dis 
 http://ard.bmj.com/content/73/11/2054
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://ard.bmj.com/content/73/11/2054
This article cites 20 articles, 7 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (968)Genetics
 (3258)Rheumatoid arthritis
 (4951)Musculoskeletal syndromes
 (4641)Degenerative joint disease
 (4253)Connective tissue disease
 (725)Calcium and bone
 (417)Ankylosing spondylitis
 (5144)Immunology (including allergy)
 (593)Open access
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on April 5, 2017 - Published by http://ard.bmj.com/Downloaded from 
